534 related articles for article (PubMed ID: 10751842)
1. Topical antipsoriatics.
Smith KC; Lebwohl M
Skin Therapy Lett; 2000; 5(2):1-2. PubMed ID: 10751842
[TBL] [Abstract][Full Text] [Related]
2. [Topical treatments for psoriasis in 2009].
Thielen AM; Laffitte E
Rev Med Suisse; 2009 Apr; 5(200):876, 878-81. PubMed ID: 19438087
[TBL] [Abstract][Full Text] [Related]
3. Drug interactions in psoriasis: the pros and cons of combining topical psoriasis therapies.
Endzweig-Gribetz CH; Brady C; Lynde C; Sibbald D; Lebwohl M
J Cutan Med Surg; 2002; 6(3 Suppl):12-6. PubMed ID: 11976987
[No Abstract] [Full Text] [Related]
4. Topical psoriasis therapy.
Federman DG; Froelich CW; Kirsner RS
Am Fam Physician; 1999 Feb; 59(4):957-62, 964. PubMed ID: 10068717
[TBL] [Abstract][Full Text] [Related]
5. A comparative study of calcipotriol and anthralin for chronic plaque psoriasis in a day care treatment center.
Dutz JP; Lui H
Int J Dermatol; 1998 Jan; 37(1):51-3. PubMed ID: 9522242
[TBL] [Abstract][Full Text] [Related]
6. Topical agents for the treatment of psoriasis, past, present and future.
Tremblay JF; Bissonnette R
J Cutan Med Surg; 2002; 6(3 Suppl):8-11. PubMed ID: 11976984
[No Abstract] [Full Text] [Related]
7. Corticosteroids: options in the era of steroid-sparing therapy.
Del Rosso J; Friedlander SF
J Am Acad Dermatol; 2005 Jul; 53(1 Suppl 1):S50-8. PubMed ID: 15968264
[TBL] [Abstract][Full Text] [Related]
8. A comparison of twice-daily calcipotriol ointment with once-daily short-contact dithranol cream therapy: quality-of-life outcomes of a randomized controlled trial of supervised treatment of psoriasis in a day-care setting.
de Korte J; van der Valk PG; Sprangers MA; Damstra RJ; Kunkeler AC; Lijnen RL; Oranje AP; de Rie MA; de Waard-van der Spek FB; Hol CW; van de Kerkhof PC
Br J Dermatol; 2008 Feb; 158(2):375-81. PubMed ID: 18067483
[TBL] [Abstract][Full Text] [Related]
9. Therapy of psoriasis in childhood and adolescence - a German expert consensus.
Sticherling M; Augustin M; Boehncke WH; Christophers E; Domm S; Gollnick H; Reich K; Mrowietz U
J Dtsch Dermatol Ges; 2011 Oct; 9(10):815-23. PubMed ID: 21585653
[TBL] [Abstract][Full Text] [Related]
10. A systematic review of adverse effects associated with topical treatments for psoriasis.
Bruner CR; Feldman SR; Ventrapragada M; Fleischer AB
Dermatol Online J; 2003 Feb; 9(1):2. PubMed ID: 12639460
[TBL] [Abstract][Full Text] [Related]
11. [Classical topical therapy of psoriasis].
Gerdes S; Mrowietz U
Hautarzt; 2006 Aug; 57(8):666-71. PubMed ID: 16841204
[TBL] [Abstract][Full Text] [Related]
12. Topical therapy for psoriasis.
Lebwohl M; Abel E; Zanolli M; Koo J; Drake L
Int J Dermatol; 1995 Oct; 34(10):673-84. PubMed ID: 8537153
[No Abstract] [Full Text] [Related]
13. Topical corticosteroid therapy in psoriasis vulgaris: update and new strategies.
Trozak DJ
Cutis; 1999 Nov; 64(5):315-8. PubMed ID: 10582155
[TBL] [Abstract][Full Text] [Related]
14. Psoriasis symposium. Topical therapy.
Menter A
Semin Dermatol; 1992 Dec; 11(4 Suppl 1):5-10. PubMed ID: 1337263
[No Abstract] [Full Text] [Related]
15. Clinical efficacy and safety of tazarotene: optimizing clinical results.
Lebwohl M
Cutis; 1998 Feb; 61(2 Suppl):27-9. PubMed ID: 9787989
[TBL] [Abstract][Full Text] [Related]
16. Topical management of psoriasis - corticosteroids and sparing corticosteroid therapy.
Gorgievska Sukarovska B; Lipozencić J
Acta Dermatovenerol Croat; 2006; 14(3):188-96. PubMed ID: 17010269
[TBL] [Abstract][Full Text] [Related]
17. Childhood psoriasis: often favorable outcome.
Prescrire Int; 2009 Dec; 18(104):275. PubMed ID: 20027717
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic progress. II: Treatment of psoriasis.
Lewis HM
J Clin Pharm Ther; 1994 Aug; 19(4):223-32. PubMed ID: 7527403
[TBL] [Abstract][Full Text] [Related]
19. Topical Therapies for Psoriasis: Improving Management Strategies and Patient Adherence.
Stein Gold LF
Semin Cutan Med Surg; 2016 Mar; 35(2 Suppl 2):S36-44; quiz S45. PubMed ID: 27074696
[TBL] [Abstract][Full Text] [Related]
20. Comparison of tazarotene 0.1% gel plus petrolatum once daily versus calcipotriol 0.005% ointment twice daily in the treatment of plaque psoriasis.
Tzung TY; Wu JC; Hsu NJ; Chen YH; Ger LP
Acta Derm Venereol; 2005; 85(3):236-9. PubMed ID: 16040409
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
